(TCAF) T. Rowe Price - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US87283Q8675

Equity, Large-Cap, Technology, Healthcare

Description: TCAF T. Rowe Price November 05, 2025

The T. Rowe Price Large Blend ETF (ticker TCAF) allocates at least 80% of its net assets-including any investment-purpose borrowings-to equities, primarily large-cap U.S. stocks. While it can hold companies of any market size, its portfolio leans heavily toward large-cap firms and may tilt toward information-technology and healthcare sectors, resulting in a non-diversified concentration profile.

As of the latest filing, TCAF carries an expense ratio of 0.20% and manages roughly $1.2 billion in assets under management (AUM). Its top five holdings typically represent about 30% of the fund, with the IT sector accounting for ~25% and healthcare ~15% of total weight. Recent macro drivers-such as the Federal Reserve’s interest-rate stance and U.S. consumer-spending trends-directly influence the performance of these sectors, making the fund sensitive to both monetary policy shifts and health-care expenditure cycles.

For a deeper, data-driven view of TCAF’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.

TCAF ETF Overview

Market Cap in USD 6,054m
Category Large Blend
TER 0.31%
IPO / Inception 2023-06-14

TCAF ETF Ratings

Growth Rating 84.2%
Fundamental -
Dividend Rating 39.5%
Return 12m vs S&P 500 -1.93%
Analyst Rating -

TCAF Dividends

Dividend Yield 12m 0.38%
Yield on Cost 5y 0.57%
Annual Growth 5y 104.23%
Payout Consistency 100.0%
Payout Ratio %

TCAF Growth Ratios

Growth Correlation 3m 92.5%
Growth Correlation 12m 68.3%
Growth Correlation 5y 94.2%
CAGR 5y 19.18%
CAGR/Max DD 3y (Calmar Ratio) 1.17
CAGR/Mean DD 3y (Pain Ratio) 10.05
Sharpe Ratio 12m 1.45
Alpha 0.40
Beta 0.000
Volatility 13.62%
Current Volume 1098k
Average Volume 20d 1070.9k
Stop Loss 37.3 (-3.1%)
Signal 0.78

What is the price of TCAF shares?

As of November 05, 2025, the stock is trading at USD 38.51 with a total of 1,098,000 shares traded.
Over the past week, the price has changed by -1.66%, over one month by +0.21%, over three months by +5.39% and over the past year by +17.63%.

Is T. Rowe Price a good stock to buy?

Yes. Based on ValueRay's Analyses, T. Rowe Price (NYSE ARCA:TCAF) is currently (November 2025) a good stock to buy. It has a ValueRay Growth Rating of 84.24 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TCAF is around 37.79 USD . This means that TCAF is currently overvalued and has a potential downside of -1.87%.

Is TCAF a buy, sell or hold?

T. Rowe Price has no consensus analysts rating.

What are the forecasts/targets for the TCAF price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 42.4 10%

TCAF Fundamental Data Overview November 04, 2025

Market Cap USD = 6.05b (6.05b USD * 1.0 USD.USD)
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 6.05b USD (6.05b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 6.05b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 6.05b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.16% (E(6.05b)/V(6.05b) * Re(9.16%) + (debt-free company))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for TCAF ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle